Filed: 2/15/2023ACC: 0001343781-23-000001
📋 What this filing means
HEALTHCOR MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 22 equity positions with a total reported market value of $109.11M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
22
Positions
$109.11M
Total AUM (reported)
6.33M
Total Shares
Allocation by class
COM$90.63M83.1%
COM NEW$9.06M8.3%
COMMON STOCK$3.27M3.0%
COM CL A$3.26M3.0%
SHS$2.87M2.6%
*W EXP 12/17/202$9.5K0.0%
*W EXP 10/23/202$4.3K0.0%
Portfolio Concentration
Top 3$81.99M75.1%
4–10$17.59M16.1%
11–25$9.54M8.7%
Top 3 weight
75.1%
Top 10 weight
91.3%
Voting Authority Distribution
Total shares with voting rights: 6.33M
Sole
Full voting authority
6.33M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole22
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings22
Rows:
BIOMARIN PHARMACEUTICAL INC
SOLEShares367.76K
TypeSH
Market value$38.06M
34.88%
Sole
367.76K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares321.38K
TypeSH
Market value$36.39M
33.35%
Sole
321.38K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares164.44K
TypeSH
Market value$7.53M
6.91%
Sole
164.44K
Shared
0.00
None
0.00
ACRIVON THERAPEUTICS INC
SOLEShares284.20K
TypeSH
Market value$3.27M
3.00%
Sole
284.20K
Shared
0.00
None
0.00
HYPERFINE INC
SOLEShares3.88M
TypeSH
Market value$3.26M
2.99%
Sole
3.88M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares110K
TypeSH
Market value$2.87M
2.63%
Sole
110K
Shared
0.00
None
0.00
CONMED CORP
SOLEShares27.50K
TypeSH
Market value$2.44M
2.23%
Sole
27.50K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares20K
TypeSH
Market value$2.39M
2.19%
Sole
20K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares70K
TypeSH
Market value$1.78M
1.63%
Sole
70K
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares60K
TypeSH
Market value$1.57M
1.44%
Sole
60K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares5.75K
TypeSH
Market value$1.53M
1.40%
Sole
5.75K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares30K
TypeSH
Market value$1.31M
1.20%
Sole
30K
Shared
0.00
None
0.00
GERON CORP
SOLEShares500K
TypeSH
Market value$1.21M
1.11%
Sole
500K
Shared
0.00
None
0.00
PENUMBRA INC
SOLEShares5K
TypeSH
Market value$1.11M
1.02%
Sole
5K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares50K
TypeSH
Market value$978.5K
0.90%
Sole
50K
Shared
0.00
None
0.00
RAIN ONCOLOGY INC
SOLEShares120K
TypeSH
Market value$960.0K
0.88%
Sole
120K
Shared
0.00
None
0.00
INSPIRE MED SYS INC
SOLEShares3.50K
TypeSH
Market value$881.6K
0.81%
Sole
3.50K
Shared
0.00
None
0.00
SILK RD MED INC
SOLEShares15K
TypeSH
Market value$792.8K
0.73%
Sole
15K
Shared
0.00
None
0.00
IMMUNOGEN INC
SOLEShares150K
TypeSH
Market value$744.0K
0.68%
Sole
150K
Shared
0.00
None
0.00
EQRX INC
SOLEShares35.24K
TypeSH
Market value$9.5K
<0.01%
Sole
35.24K
Shared
0.00
None
0.00
EUCRATES BIOMEDICAL ACQU COR
SOLEShares78.06K
TypeSH
Market value$4.3K
<0.01%
Sole
78.06K
Shared
0.00
None
0.00
MEDICUS SCIENCES ACQUISITION
SOLEShares29.78K
TypeSH
Market value$2.7K
<0.01%
Sole
29.78K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 367.76K | SH | $38.06M 34.88% | 367.76K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 321.38K | SH | $36.39M 33.35% | 321.38K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 164.44K | SH | $7.53M 6.91% | 164.44K | 0.00 | 0.00 |
ACRIVON THERAPEUTICS INCSOLE | COMMON STOCK | 284.20K | SH | $3.27M 3.00% | 284.20K | 0.00 | 0.00 |
HYPERFINE INCSOLE | COM CL A | 3.88M | SH | $3.26M 2.99% | 3.88M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 110K | SH | $2.87M 2.63% | 110K | 0.00 | 0.00 |
CONMED CORPSOLE | COM | 27.50K | SH | $2.44M 2.23% | 27.50K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 20K | SH | $2.39M 2.19% | 20K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 70K | SH | $1.78M 1.63% | 70K | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | COM | 60K | SH | $1.57M 1.44% | 60K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 5.75K | SH | $1.53M 1.40% | 5.75K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 30K | SH | $1.31M 1.20% | 30K | 0.00 | 0.00 |
GERON CORPSOLE | COM | 500K | SH | $1.21M 1.11% | 500K | 0.00 | 0.00 |
PENUMBRA INCSOLE | COM | 5K | SH | $1.11M 1.02% | 5K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 50K | SH | $978.5K 0.90% | 50K | 0.00 | 0.00 |
RAIN ONCOLOGY INCSOLE | COM | 120K | SH | $960.0K 0.88% | 120K | 0.00 | 0.00 |
INSPIRE MED SYS INCSOLE | COM | 3.50K | SH | $881.6K 0.81% | 3.50K | 0.00 | 0.00 |
SILK RD MED INCSOLE | COM | 15K | SH | $792.8K 0.73% | 15K | 0.00 | 0.00 |
IMMUNOGEN INCSOLE | COM | 150K | SH | $744.0K 0.68% | 150K | 0.00 | 0.00 |
EQRX INCSOLE | *W EXP 12/17/202 | 35.24K | SH | $9.5K <0.01% | 35.24K | 0.00 | 0.00 |
EUCRATES BIOMEDICAL ACQU CORSOLE | *W EXP 10/23/202 | 78.06K | SH | $4.3K <0.01% | 78.06K | 0.00 | 0.00 |
MEDICUS SCIENCES ACQUISITIONSOLE | *W EXP 02/12/202 | 29.78K | SH | $2.7K <0.01% | 29.78K | 0.00 | 0.00 |